Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

Apr 8, 2021

29821_dirs_2021-04-08_a4030a46-64b8-4639-9de8-7bbc5466a687.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-04-06

Reporting Person: BOSTON SCIENTIFIC CORP (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-06 Common Stock S 650000.0000 $43.6000 Disposed 3988106.0000 Direct

Footnotes

F1: These shares of the Issuer's common stock were sold in a block order at a price of $43.60.